Dose, tolerance, digestion, food, and product type all matter
Any medication decision for type 2 diabetes should be made alongside the support of your doctor and healthcare team, as the rewards are associated with risks
He has over 30 years of experience in pharmaceutical drug development, specializing in topical and transdermal products, and producing numerous research manuscripts, review articles, book chapters and patents
GLP-1 agonists are promising for MASH treatment because they target multiple aspects of the disease, including fat accumulation, inflammation, and insulin resistance, which are all key factors in MASH progression
Monthly costs can get expensive, depending on the GLP-1 youre taking
Acknowledgements We thank the doctors, nurses, and technicians for their dedicated work during the study at the Department of Endocrinology and Metabolism in Peking University Peoples Hospital